Statistics on Biotechnology Use  
Results by sector of operation
Sector Companies. Results in biotechnology for main variables and branches of activity 
Unidades: specified in variables

,Total Companies,Services,Industry and Construction,Agriculture,
No. of companies carrying out R&D in Biotechnology,1.078,695,298,85,
%Companies according to biotechnology used: Genetic code,35,43,16,38,
%Companies according to biotechnology used: Functional units,42,45,40,18,
%Companies according to biotechnology used: Cellular and tissue culturing and engineering,27,30,18,29,
%Companies according to biotechnology used: Bioprocesses,49,41,72,32,
%Companies according to biotechnology used: Sub-cellular organisms,8,10,4,1,
%Companies according to biotechnology used: Bio-computing,22,30,6,7,
%Companies according to biotechnology used: Nanobiotechnology,14,18,7,1,
%Companies according to biotechnology used: Other,12,12,10,16,
Companies in which biotechnology activities are: Main and/or exclusive,526,448,71,7,
Companies in which biotechnology activities are: A secondary line of business,173,101,61,11,
Companies in which biotechnology activities are: A tool necessary for production,379,146,166,68,
%Company by field(s) of ultimate application of biotechnology use: Human Health,48,63,27,4,
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture,20,20,16,33,
%Company by field(s) of ultimate application of biotechnology use: Food products,33,25,50,35,
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production,24,21,19,60,
%Company by field(s) of ultimate application of biotechnology use: Environment,15,16,15,9,
%Company by field(s) of ultimate application of biotechnology use: Industry,14,16,10,1,
Personnel in R&D in biotechnology (no. of persons),10.191,6.743,2.733,715,
Personnel in R&D in biotechnology (no. of persons): Researchers,5.774,4.260,1.267,247,
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants,4.417,2.483,1.466,468,
Personnel in R&D in biotechnology (no. of persons): women,5.525,3.876,1.350,298,
Personnel in R&D in biotechnology (no. of persons): (women) Researchers,3.015,2.286,637,91,
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants,2.511,1.590,713,207,
Personnel in R&D in biotechnology (FTE),7.191,4,4.952,9,1.826,7,411,7,
Personnel in R&D in biotechnology (FTE): Researchers,4.276,6,3.198,6,917,6,160,4,
Personnel in R&D in biotechnology (FTE): Technicians and assistants,2.914,7,1.754,3,909,1,251,3,
Personnel in R&D in biotechnology (FTE): women,3.985,4,2.831,9,953,7,199,8,
Personnel in R&D in biotechnology (FTE): (women) Researchers,2.234,1.696,3,475,9,61,8,
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants,1.751,4,1.135,6,477,9,137,9,
Internal expenditure on R&D (thousands of euros),578.171,395.589,159.179,23.403,
1) By nature of the expense: Current expenses,517.601,349.562,146.112,21.927,
1.1) Remuneration to researchers,213.755,151.067,55.410,7.278,
1.2) Remuneration to technicians and assistants,98.440,55.120,36.579,6.741,
1.3) Other current expenses,205.406,143.375,54.123,7.908,
2) By nature of the expense: Capital expenses,60.570,46.027,13.067,1.476,
2.1) Land and buildings,22.609,21.356,1.165,87,
2.2) Equipment and instruments,36.169,22.930,11.860,1.379,
2.3) Acquisition of specific R&D software,1.793,1.741,42,10,
1) By origin of the funds: National funds,487.615,340.944,125.565,21.105,
1.1) Own funds,330.459,193.495,117.264,19.701,
1.2) From companies,45.462,42.794,2.668,.,
1.3) Public Administration funds,66.189,59.179,5.605,1.405,
1.4) From Universities,25.148,25.119,29,.,
1.5) From non profit private institutions,20.357,20.357,.,.,
1) By origin of the funds: Foreign funds,90.556,54.645,33.614,2.298,
2.1) From EU programmes,20.932,20.111,802,20,
2.2) Other foreign funds,69.624,34.534,32.812,2.278,
Purchase of R&D services in biotechnology (thousands of euros),166.022,90.846,73.316,1.860,
Purchase of R&D services in biotechnology (thousands of euros): In Spain,97.455,49.037,47.171,1.247,
Purchase of R&D services in biotechnology (thousands of euros): Abroad,68.567,41.809,26.144,614,
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital,46,54,32,31,
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information,13,12,17,14,
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources,14,14,15,12,
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain,14,16,11,7,
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets,17,20,12,14,
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of distribution and sales channels,17,20,11,11,
%Companies that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception,18,18,17,20,
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements,35,36,36,28,
%Companies that consider the following obstacles as very important considering biotechnology development: Time / cost,49,51,43,51,
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting,21,22,19,19,
% Companies that have requested biotechnology patents in Biotechnology,15,19,10,5,
Number of patents requested,526,390,99,37,
% Companies with income of an international origin related to biotechnological activities,26,27,25,7,18,9,
% Turnover representing income of an international origin related to biotechnological activities,1,4,6,6,1,1,1,3,
% Income of an international origin related to biotechnological activities distributed in: Income received from the EU,63,8,44,1,72,2,67,
% Income of an international origin related to biotechnological activities distributed in: Income received from other countries,36,2,55,9,27,8,33,
% Income of an international origin related to biotechnological activities by classification: Internacional trade in products and services,91,6,76,6,98,5,77,6,
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain,0,9,0,5,0,4,22,4,
% Income of an international origin related with activities according to the classification: Operating source abroad,1,9,5,7,0,3,.,
% Income of an international origin related with activities according to the classification: Other,5,6,17,2,0,8,.,
Notas:

.
'.'=numeric piece of data equal to zero not resulting from rounding 

 FTE: Full Time Equivalent
Fuente: National Statistics Institute